Our Mission:
Accelerating the prevention and cure of myeloma and improving
the quality of life for patients and families
I am a...
About Multiple Myeloma
Multiple myeloma starts in the bone marrow plasma cells. It weakens the immune system and can affect many parts of the body by causing the bone marrow to create dysfunctional antibodies and plasma cells. Living with or treating this disease means making complicated decisions, and this requires searching for reliable, current information on multiple myeloma.
How Can the International Myeloma Foundation Help?
The International Myeloma Foundation (IMF) connects people to what matters most — research that pushes the field forward, education that clarifies complex topics, support tailored to individual needs, and advocacy that amplifies every voice. Patients, care partners, healthcare professionals, and researchers can access the knowledge, resources, and community they need from the IMF to navigate life with myeloma.
Awareness is the first step toward a cure.
The more people know about myeloma, the louder our call becomes for:
Earlier diagnosis
Greater access to treatments
More investment in myeloma research
Equity in cancer care
Too many people still say, "What’s myeloma?" In 2026, we’re changing that — together. Learn how you can get involved in Blood Cancer Awareness Month.
This week’s blog covers the latest myeloma research from August-September 2026. It includes a 2026 clinical update on diagnosis, risk stratification, and management of myeloma; a review on bispecific antibodies and T-cell engagers in myeloma, and more. Get the latest on myeloma clinical trials, as well as news from NICE (UK). READ THE BLOG.
At the 23rd International Myeloma Society (IMS) Annual Meeting & Exposition, international experts presented new criteria that could identify when a patient’s remission is durable enough to be called a cure. Myeloma has always been incurable, as the vast majority of patients relapse after initial therapy and have shorter life expectancy. However, because of outstanding advances in the field, this is changing. The 23rd Annual Meeting of the IMS in Glasgow, Scotland, is currently ongoing. At this meeting, the IMS and the IMF’s International Myeloma Working Group (IMWG) proposed a working definition of cure. LEARN MORE.
Join Dr. Douglas Sborov for a Facebook Live Q&A on September 29, 2026, at 4 p.m. PT | 7 p.m. ET. He’ll answer your questions about myeloma, treatment advances, patient care, and more. You do not need a Facebook account to join. RSVP “Going” on Facebook: RSVP NOW.
The IMF Myeloma Community Workshops (MCWs) offer shorter, yet still robust, programming for free. We encourage you to find a workshop in a city near you: San Diego, CA; or Phoenix, AZ. Also, be sure to check out this virtual MCW: What's the Right Answer? - Controversies in Myeloma. Seating is limited, so register today! REGISTER NOW.
When you volunteer to organize a community fundraiser for the IMF, you receive support and guidance from the IMF's Development Team. Whether it's a 5K Walk/Run, a bake sale, or a simple letter-writing campaign, we're here to help you.
